IL-23/IL-17 axis in spondyloarthritis-bench to bedside

Clin Rheumatol. 2016 Jun;35(6):1437-41. doi: 10.1007/s10067-016-3263-4. Epub 2016 Apr 13.

Abstract

Cytokines play a critical role in the pathogenesis of psoriatic arthritis, ankylosing spondylitis, and other types of spondyloarthritis (SpA). Besides IFN-γ and TNF-α; IL-23/IL-17 cytokines play a dominant role in the inflammatory and proliferative cascades of SpA. Recently, in a series of elegant experiments using mouse models and human tissues, it has been demonstrated that IL-23-induced Th17 cytokines (IL-17 and IL-22) can contribute to following pathologic events associated with SpA: development of psoriatic plaque, pannus formation in the joint, joint erosion, and new bone formation. In this review article, we have discussed the contributing role of the IL-23/IL-17 cytokine axis in the pathogenesis of PsA and AS. IL-23/IL-17-targeted therapies are very promising for SpA, and we have provided an outline about usefulness of these new groups of biologics in SpA.

Keywords: Ankylosing spoindylitis; IL-17; IL-23; Psoriatic arthritis; Spondyloarthritis; Th17 Cell.

Publication types

  • Review

MeSH terms

  • Animals
  • Arthritis, Psoriatic / pathology
  • Humans
  • Interleukin-17 / immunology*
  • Interleukin-23 / immunology*
  • Mice
  • Spondylitis, Ankylosing / immunology*
  • Spondylitis, Ankylosing / pathology
  • Th17 Cells / immunology*

Substances

  • Interleukin-17
  • Interleukin-23